Currently, there is no treatment available for the cure or prevention of Huntington disease. Most of the treatment and interventions available are supportive. These include medications to help control erratic behavior and movements, physical and occupational therapy as well as therapy for speech and in help swallowing, and counseling and caregiver support. In 2008, the drug tetrabenazine became the first medication approved by the U.S. Food and Drug Administration (FDA) to treat the involuntary movements characteristic of HD. Research is ongoing in an effort to develop targeted drug therapies for this disease. Current research pursuing gene therapies for treating HD could eventually prove useful; however, the technology is still in its infancy.